Join New York Times columnist David Brooks as he engages the authors of “Brainwashed: The Seductive Appeal of Mindless Neuroscience” Sally Satel and Scott Lilienfeld, in a discussion of popular neuroscience.

At this event, Paul Spitalnic, Medicare’s acting chief actuary, will explain the results of this year’s Medicare trustees report. A panel of experts will then discuss how developments in the health sector will affect Medicare’s long-term future.

Mark Warshawsky, a well-known expert in retirement finance and a newly appointed commissioner, will explain the implications of a publicly funded long-term care insurance program. Then a panel will debate whether another government program the best way to ensure that families can afford to provide the necessary services for their aging loved ones.

Scott Gottlieb's testimony for the House Energy and Commerce Committee, Subcommittee on Health's hearing on drug compounding.

Medicare has sharply changed the way it pays for diagnostic tests, cutting payment rates and curtailing coverage for some new tests altogether.

This history of Obamacare’s political origins makes it all the more ironic that Obamacare, from what we now know, should not be considered a “universal coverage” plan, even by the benchmark the administration was using in 2009.

Would you like to have a "skinny" health insurance policy? Probably not. But if you're employed by a large company you may get one, thanks to Obamacare.

Joseph Antos' testimony before the House Committee on Ways and Means' Subcommittee on Health on "The President’s and Other Bipartisan Proposals to Reform Medicare."

The Internal Revenue Service is facing a class action lawsuit alleging that more than 60 million personal medical records were improperly seized by agents from the embattled agency.

So how do you feel about turning over access to some of your most sensitive healthcare information to the Internal Revenue Service?